RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
- Fatma YILMAZ
- Murat ALBAYRAK
- Merih REİS ARAS
- Senem MARAL
- Hacer Berna AFACAN ÖZTÜRK
- Pınar TIĞLIOĞLU
- Mesut TIĞLIOĞLU
- Buğra SAĞLAM
Publication date
November 2021
DOI Publisher
Elsevier BV Journal
Hematology Transfusion and Cell TherapyAbstract
Case report: One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects
Add to ORKG